Fabio Infusino

ORCID: 0000-0003-2606-657X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • COVID-19 Clinical Research Studies
  • Heart Failure Treatment and Management
  • COVID-19 and healthcare impacts
  • Cardiac Structural Anomalies and Repair
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • Heart rate and cardiovascular health
  • Coronary Interventions and Diagnostics
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Arrest and Resuscitation
  • COVID-19 and Mental Health
  • Infective Endocarditis Diagnosis and Management
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Mechanical Circulatory Support Devices
  • Cardiovascular Issues in Pregnancy
  • Cardiac Arrhythmias and Treatments
  • Acute Myocardial Infarction Research
  • Cardiac pacing and defibrillation studies
  • Phonocardiography and Auscultation Techniques
  • Atrial Fibrillation Management and Outcomes
  • Heart Rate Variability and Autonomic Control
  • Cardiac Health and Mental Health

Ospedale Maggiore
2024

Policlinico Umberto I
2019-2022

Sapienza University of Rome
2019-2022

Institute of Cardiology
2021

The balloon-expandable Sapien-3 valve demonstrated superior results in terms of residual aortic regurgitation when compared with self-expandable devices. We aimed to compare for the first-time early outcomes transcatheter heart (THV) Myval device.Consecutive real-world patients from nine European institutions symptomatic severe stenosis treated either or THV devices after June 2018 were compared. Early clinical prospectively gathered and blinded analysis 30-day echocardiography was...

10.1136/heartjnl-2021-319349 article EN Heart 2021-07-20

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes the angiotensin-converting enzyme-2 (ACE-2) receptor to enter human cells. Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II antagonists (ARB) are associated with ACE-2 upregulation. We hypothesized that antecedent use of ACEI/ARB may be mortality in disease 2019 (COVID-19). Methods Results used Coracle registry, which contains data patients hospitalized COVID-19 4 regions Italy, restricted...

10.1161/jaha.120.017364 article EN cc-by-nc-nd Journal of the American Heart Association 2020-10-07

Abstract Aims The recent coronavirus disease 19 (COVID‐19) pandemic outbreak forced the adoption of restraint measures, which modified hospital admission patterns for several diseases. aim study is to investigate rate admissions heart failure (HF) during early days COVID‐19 in Italy, compared with a corresponding period previous year and an earlier same year. Methods results We performed retrospective analysis on HF number at eight hospitals Italy throughout (21 February 31 March 2020),...

10.1002/ehf2.13043 article EN cc-by-nc ESC Heart Failure 2020-10-23

Ischaemic heart disease is classically associated with coronary artery disease. Recent evidences showed the correlation between microvascular dysfunction and ischaemic disease, even independently of Ion channels represent final effectors blood flow regulation mechanisms their genetic variants, in particular Kir6.2 subunit ATP-sensitive potassium channel (KATP), are reported to be involved susceptibility. The aim present study evaluate role KATP its variants patients whether differences exist...

10.1177/2047487320926780 article EN European Journal of Preventive Cardiology 2020-06-02

Despite a successful percutaneous coronary intervention (PCI), several studies reported that the recurrence of angina after revascularization, even complete, is particularly frequent occurrence in first year PCI. The aim was to evaluate efficacy treatment with ranolazine addition conventional anti-ischemic therapy patients who underwent angiography for persistent/recurrent PCI and residual ischemia only due small branches not suitable further revascularization. Forty-nine consecutive were...

10.3390/jcm9072110 article EN Journal of Clinical Medicine 2020-07-04

Residual angina after PCI is a frequently occurring disease. Ivabradine improves symptoms but its role in patients without left ventricular systolic dysfunction still unclear. The aim was to quantify the effects of ivabradine terms MVO2 indicators and diastolic function. Twenty-eight consecutive with residual were randomized 5 mg twice/day (IG) or standard therapy (CG). All performed stress echocardiography at enrollment 30 days. estimated from double product (DP) triple (TP) integrating DP...

10.1155/2019/9185876 article EN cc-by Cardiology Research and Practice 2019-04-01

Ischemic heart disease is the most common cause of death in both female and male genders. Though coronary artery determinant ischemia males, women present more often chest pain associated with normal epicardial arteries. In females, microvascular dysfunction plays a key role developing symptoms imbalance between delivery request blood flow. Coronary ion channels play major regulation According to epidemiological, pathophysiological clinical differences genders ischemic diseases, it...

10.4172/1747-0862.1000409 article EN Journal of Molecular and Genetic Medicine 2019-01-01

Infusino, Fabio; Calcagno, Simone; Cimino, Sara; Pucci, Mariateresa; Salvi, Nicolò; Maestrini, Viviana; Severino, Paolo; De Carlo, Carlotta; Colantonio, Riccardo; Sardella, Gennaro; Mancone, Massimo; Fedele, Francesco Author Information

10.2459/jcm.0000000000001069 article EN Journal of Cardiovascular Medicine 2020-07-18
Coming Soon ...